People often ask what we know here about the CGRPs, and all we can say is what we have seen anecdotally. Here's a recent study that shows they might have some benefits, but not as much as we had hoped.
Efficacy and safety of CGRP monoclonal antibodies for cluster headache: a systematic review and network meta-analysis of randomized controlled trials | Neurological Sciences | Springer Nature Link